Latest in Bladder & Kidney Cancer

742 words

CatalYm Presents Phase 2 Data Showing Visugromab Substantially Enhances the Clinical Benefit of PD-1 Inhibition in Neoadjuvant Bladder Cancer at ESMO 2026

CatalYm today announced final results from its randomized Phase 2 GDFATHER-NEO trial, which were presented in a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 and simultaneously published in Nature Medicine. The data showed that Growth Differentiation…

cancer.org
513 words

Bladder Cancer Signs and Symptoms

1 in 8 women in the US will be diagnosed with breast cancer during their lifetime. Help fund lifesaving research and access to care, giving families like Gina’s more moments together. The amount must be greater than or equal to $5 Bladder cancer…

med.stanford.edu
140 words

Stanford Urology Hosts 2025 Research Day

Stanford Urology welcomed faculty, residents, postdoctoral scholars, researchers, and invited experts from across the School of Medicine for the 2025 edition of 5th Annual Research Day. The program, annually led and hosted by Joseph Liao, MD, Professor of Urology, Director of Research,…

finance.yahoo.com
293 words

Urine Tumor Deoxyribonucleic Acid (DNA) Testing Global Market Report 2026 | Capitalize on 14.9% CAGR as Roche, Illumina, QIAGEN and Pangea Scale AI-Driven Liquid Biopsies

Company profiles cover urine tumor DNA testing products, technologies, applications and market activity. Dublin, Oct. 29, 2026 (GLOBE NEWSWIRE) -- "Urine Tumor Deoxyribonucleic Acid (DNA) Testing Global Market Report 2026" has been added to ResearchAndMarkets.com's offering. The global urine tumor deoxyribonucleic acid (DNA)…

Bladder & Kidney Cancer

Bladder cancer and kidney cancer, including renal cell and urothelial carcinoma: symptoms, diagnosis, treatment and research.

  • 11 Tracked terms
  • Last 30 days Feed window

What this topic collects on

An article joins this feed when it matches these terms. Each one is also a search of its own.